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Abstract:
Introduction: The underlying problem for two
of the three most common patterns of
unexpected hospital deaths (PUHD) is
hypoventilation1. Concern over this opioidinduced respiratory depression has led many
experts and consensus guidelines to
recommend that all patients receiving
opioids be monitored for respiratory rate.
Currently, no clinically accepted “goldstandard” monitoring device exists for nonintubated, spontaneously breathing patients.
We studied seven distinct respiratory
sensors to compare their effectiveness in
respiratory monitoring. Methods: With IRB
approval, data were collected from 26
volunteers who were administered target
controlled infusions of remifentanil and
propofol in order to induce low respiratory
rates. Data were collected from a suite of
sensors which were analyzed using a single,
custom breath detection algorithm. Breath
rates
derived from a capnometer,
accelerometer, oro-nasal thermistor, nasal
pressure
transducer,
microphone,
photoplethysmogram,
and
impedance
respiratory sensor were compared against
breath rates derived from the reference
standard
of
respiratory
inductance
plethysmography bands at both low and
normal respiratory rate ranges. Results:
Capnometry and acceleromtry reported
respiratory rates closest to those reported by
the respiratory inductance plethysmography
bands. Conclusion: Detecting respiratory
rate in the post-operative environment is a
clinically challenging problem which likely
requires further study.

INTRODUCTION & BACKGROUND
The underlying problem for two of the three
most common patterns of unexpected
hospital deaths (PUHD) is hypoventilation1.
Type II PUHD (CO2 narcosis) involves a
reduction in respiratory rate and/or tidal
volume, and if supplemental oxygen is being
provided, a pulse oximeter will not detect the
problem until the hypercarbia is significantly
advanced and the patient is near respiratory
arrest. Type III PUHD is induced by
obstructive sleep apnea in the presence of
arousal failure, and is recognized as a
repetitive sequence of cyclic apneas and
self-arousals which precede the final apnea.
A pulse oximeter alarms with each apneic
period and will likely be interpreted as
generating many false positive alarms.1 The
risk of opioid-induced respiratory depression
in postoperative patients is greatest in the
first 24 hours after initiation of opioids2, and
opioids are the most commonly used drug for
treating pain in the postoperative period.3
These problems would be especially
troublesome during long-range, manned
space missions where monitoring personnel
are limited due to either sedation of crew
members or an injury rendering the crew
short-handed.
Respiratory depression is caused by druginduced inhibition of the breathing control
center of the brain stem. Partial to full airway
obstruction is an anatomic problem involving
the soft palate, tongue base, and/or
epiglottis,
caused
by
drug-induced
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decreases in airway patency and muscle
tone. Sedatives and opioids depress the
response to elevated CO2 (reduced drive to
breathe), worsen arousal, cause airway
obstruction, and change sleep patterns4-8
In the postoperative period, most adverse
respiratory events occur during the first 24
hours of opioid administration.2 During this
period,
pulse
oximeter
monitoring,
supplemental oxygen, incentive spirometry,
and intermittent nursing observation are the
primary interventions used to fend off
adverse respiratory events. For inpatient
monitoring, pulse oximetry is often
inadequate. On a busy hospital floor, it is
difficult to respond to multiple remote
advisory pulse oximetry alarms. Pulse
oximeter alarms are ignored because they
have a high false-positive alarm rate due to
movement artifact and displacement.9,10
Pulse
oximetry
primarily
monitors
oxygenation instead of ventilation; the SpO2
signal is a delayed indicator for apnea or
hypopnea, particularly when supplemental
oxygen is given. By the time the pulse
oximeter alarms, an apneic patient is already
in danger of hypoxia, brain injury and death.
Despite exhaustive studying of respiratory
monitoring technologies, no sensor has
emerged as a clinically accepted goldstandard for non-intubated, spontaneously
breathing patients11. Monitors which are
currently used elsewhere in the healthcare
environment may not be suited to this
situation. Capnometry, often used during
intubations, relies on an adequate gas
sample from the airway which may be difficult
to obtain in the non-intubated environment.
Pulse oximetry is notoriously delayed in
detecting apnea, especially when patients
are receiving supplemental oxygen. In
addition, neither of these monitoring
modalities distinguish between central apnea

and obstructive apnea, which may influence
clinical decision making.
We suggest that there is an urgent need for
a low cost, reliable respiratory depression
monitoring technique that can be integrated
with the signals from the pulse oximeter to
give additional physiologic information about
a patient’s sufficiency of both ventilation and
oxygenation in the non-intubated setting.
Currently, we are exploring the value of
integrating the information from a set of lowcost physiologic monitors to detect
respiratory rate. Specifically, we studied a
capnometer, accelerometer, nasal pressure
transducer,
thermistor,
peri-tracheal
microphone, photoplethysmogram, chest
impedance, and respiratory inductance
plethysmography.
We tested each sensor under identical
conditions in order to reduce as many
variables as possible in the comparison.
Specifically, each sensor recorded data from
the same subjects, and during the same time
period. An identical, threshold-based breath
detection algorithm was then implemented
on each signal in order to detect breathing.
The goal was to establish the comparative
strengths and weaknesses of each sensor in
different respiratory rate ranges.
METHODS
Informed written consent was obtained from
26 volunteers (13 male, 13 female). Eligible
volunteers had an ASA physical status of I or
II, age 18 to 55 years, body mass index
between 18 and 30 kg/m2, negative drug
screen, and uncomplicated airway anatomy.
Volunteers were not eligible if they had a
history of significant alcohol or drug abuse, a
positive drug-screening test, allergy to
opioids or propofol, obstructive sleep apnea,
any prescription medication intake other than
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oral contraceptives in the 48 hours preceding
the study, or medical illnesses that are
known to alter the pharmacokinetics or
pharmacodynamics of opioids or intravenous
anesthetics.
Volunteer subjects were instrumented with a
three lead electrocardiogram that detects
respiratory rate using chest impedance
(Datex Ohmeda, GE Healthcare, Helsinki,
Finland), a photo-plethysmography (PPG)
sensor (SET, Masimo Corporation, Irvine,
CA), an abdominal accelerometer sensor
(ADXL345, Analog Devices, Norwood, MA),
respiratory inductance plethysmography
(RIP) chest bands (Q-RIP, Braebon Medical
Corporation, Kanata, ON, Canada), a
capnometer nasal cannula (LoFlo, Philips
Medical, Wallingford CT), a nasal airway
pressure sensor (1 INCH-D-4V, All Sensors,
Morgan Hill, CA), a nasal/oral thermistor
(Disposable Adult Airflow Sensor, Braebon
Medical Corporation, Kanata, ON, Canada),
and a peri-tracheal microphone (AudioTechnica ATR3350iS. Machida, Tokio,
Japan) positioned within a metal pre-cordial
stethoscope cup (Wenger #00-390-c, AINcA,
San Marcos, CA) placed just below the
larynx and above the suprasternal notch.
Data waveforms were digitized at 100 Hz
with the exception of the acoustic waveform
which was digitized at 44.1 kHz.
A 20 gauge venous catheter was placed in
an antecubital vein under local anesthesia
(0.2 mL of 0.5% lidocaine) for the purpose of
hydration and drug administration. The IV
site was similar in all subjects. A
maintenance infusion of 0.9% sodium
chloride was administered at 1 ml/kg/hour
throughout the study. Continuous infusions
of Remifentanil and Propofol was infused
into this peripheral IV.
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Our team previously characterized various
effects of sedatives combined with opioids
using drug interaction models. Specifically,
we characterized the interaction of Propofol
and Remifentanil on metrics of airway
obstruction and intolerable ventilatory
depression in volunteers.8 Each subject
received Propofol and Remifentanil. Similar
to previously collected data from our
volunteer laboratory (Kern et al, 2004), each
drug was administered using a computer
controlled (Stanpump14) continuous infusion
pump (Pump 22; Harvard Apparatus,
Limited, Holliston, MA) to achieve selected
target effect site concentrations. The effect
site concentration refers to the drug
concentration at the pharmacologic site of
action. Pharmacokinetic
parameters
15
published by Minto et al. and Schnider et
al.16 was used for Remifentanil and Propofol
respectively.
We administered Propofol and Remifentanil
pairs in a dose escalation scheme with small
steps in order to creep up to the desired
target effects of respiratory depression,
airway obstruction and both effects while
avoiding overshoot. To accomplish this, the
Propofol was dosed in a range of 0.75 - 4
mcg/mL in dose escalation steps of
approximately 0.5 mcg/mL. Remifentanil was
dosed in a range of 0.75 to 4.0 ng/mL in
escalation steps of approximately 0.25-0.5
ng/mL.
Data were isolated from periods during which
the patient was unperturbed, not talking, and
breathing normally (no obstruction present).
Samples of all acquired waveforms and the
filteres used to process them are shown in
Figure 1.
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Figure 1: Raw signal waveforms before and after filtering. Filters used are indicated on the transitional arrows.
PPG indicates photoplethysmography.
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A custom algorithm which detects peak
prominence in each signal and compares it
to predefined thresholds was used to detect
breathing in each signal. Respiratory rate
during each acquired minute of data was
calculated for each sensor and compared to
the reference standard of respiratory
inductance plethysmography.
A Bland-Altman style analysis was
performed on two sets of data. In one set, all
respiratory rate ranges were included. In the
second set, only data where the reference
respiratory rate was 10 or fewer breaths per
minute was used. In these analyses, bias is
calculated as the mean difference in the
respiratory rates reported by the reference
and comparison sensor signals (reference
minus comparison). Standard deviation is
the square root of the statistical variance that
assumes a normal distribution. A 95%
confidence interval is calculated as bias ±
standard deviation. A sample Bland-Altman
style plot is presented in figure 2.

RESULTS
A total of 877 minutes of data fit the criteria
described in the methods. The results of the
Bland-Altman analysis which includes all
respiratory rates is presented in Table 1. The
accelerometer, nasal pressure, thermistor,
and capnometer all exhibited low bias (<.4
BPM). Impedance, photoplethysmogram,
and microphone all exhibited relatively high
bias (1.4-2 BPM). The signals with the lowest
standard deviation were the accelerometer
and the capnometer. The highest standard
deviations were exhibited by the respiratory
impedance,
photoplethysmogram,
and
microphone.
A total 407 minutes were available where the
reference signal reported a respiratory rate
of 10 or fewer breaths per minute. The
results of the Bland-Altman analysis on this
data set is presented in Table 2. All signals
exhibited low bias (-.6 BPM). The signals
with the lowest standard deviation were the
accelerometer and capnometer.
CONCLUSION
A low cost, accurate, and minimally sized
respiratory monitor would be useful during
space travel when personnel are limited
following an injury/emergency procedure or if
astronauts were to be sedated during
extended voyages.

Figure 2: Blant-Altman style plot comparing capnometry
against Respiratory Inductance Plethysmography at
respiratory rate of 10 or fewer breaths per minute.

Overall, obtaining accurate respiratory rates
in non-intubated, spontaneously breathing
volunteers is challenging. We were able to
obtain reasonably reliable respiratory rates
from two signals—an accelerometer and
capnometer. These signals generally
exhibited the lowest signal-to-noise ratio and
lowest amount of signal drop-out. The
impedance primarily struggled with a low
signal-to-noise ratio that stemmed from
cardiogenic motion. The thermistor primarily
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Table 1: Bland-Altman summary statistics for all sensors and all respiratory rate ranges. PPG
indicates photoplethysmography.
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Table 2: Bland-Altman summary statistics for all sensors and low respiratory rate ranges (10 or
fewer breaths per minute as detected by the reference signal). PPG indicates
photoplethysmography.
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struggled with high sensitivity to external
airflows. In the case of the microphone and
the photoplethysmogram, the filtering
method was a concern. Both signals have
much higher underlying frequencies (sound
and heart rate) that had to be filtered out
using an envelope filtering technique. This
method may have been imperfect for
assessing respiratory rate in these signals.
There were many other limitations to
consider when analyzing these results. All

data was collected from healthy volunteers
who instructed to lay quietly. This may not
reflect the clinical condition. Additionally,
subjects were receiving 2 L/min of oxygen
through a nasal cannula which may have had
an effect on the nasal pressure, thermistor,
and capnometer signals. Additionally, the
algorithm may not be as suited to some
signal waveforms as others (as noted in the
case of the photoplethysmogram and
microphone).
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The comparison in signal performance
between high and low respiratory rates may
help influence decision making when
choosing a sensor to monitor patients who
are at risk of developing respiratory
complications. All signals improved when
monitoring for low respiratory rates, however
the accelerometer had the highest relative
improvement, indicating it may be especially
suited to detecting these clinical conditions.
We intend to continue this analysis and
analyze how each signal performs in
detecting specific clinical pathologies.
Additionally we will study whether accuracy
can be improved through sensor fusion
techniques.
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